Cortalix B.V.
PrivateLast Round
Seed
Mar 3, 2025
Total Funding Raised
$1.09M
Company Overview
Cortalix B.V. is a biotechnology company that specializes in the discovery and engineering of single-domain antibodies (VHH or nanobodies) for applications in molecular imaging, targeted therapy, and immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Imaging, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cortalix B.V. Comparables
Compare Cortalix B.V. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sanofi | 70% | |
| GenScript | 63% | |
| Adimab | 62% | |
Cortalix B.V. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 3, 2025 |
Cortalix B.V. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovatie Fonds Rabobank | Seed |
| Future Tech Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Monthly visitors grew 410% MoM.
- Mar 3, 2025
$1.1M round led by Future Tech Ventures
Cortalix B.V. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cortalix B.V.'s valuation, stock price, and market status.